search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
SKIN CARE


This plays into the fact that phenomena which are closely linked to, for instance, skincare products have now conquered their own position in the consumer market. The use of facial skincare devices, for example, has shown strong growth in the last few years.9 Massage is another such example of a phenomenon which has gained important ground in the marketplace. Massage leads to psychological relaxation and can therefore play an important role in improving a person’s wellbeing.10,11


Skin sensitivity 3.0


Moderate In addition, massage has interesting


and potent physiological effects on skin.12,13 Bridging the gap between effective skincare


with facial massage is seemingly ubiquitous in the marketplace. A simple Google search for “facial massage” and “sensitive skin” leads to thousands of results of brands and clinics providing products and services related to facial massage for sensitive skin, many of them claiming that skin becomes less reactive and more relaxed. This is intuitively unsurprising as there is a large psychological aspect to skin sensitivity, as described above. As already mentioned, people with


sensitive, stressed skin have a relatively high level of suffering. The expectations of a cosmetic product are just as high. What does an active ingredient need to do to meet these expectations? Further, where is the measurable added value to the psychological effect that the use of cosmetic products already has, especially in combination with a facial massage?


Comparison between normal skincare and skincare + facial massage AnnonaSense CLR™ (Cherimoya; INCI: Annona Cherimola Fruit Extract) is an upcycled active ingredient from CLR which was reported on earlier. It acts as an agonist on the CB2 (Cannabinoid Receptor Type 2), thus supporting the skin in maintaining or regaining health and robustness.14 Earlier studies indeed showed that Cherimoya


was able to reduce sensitivity of skin as well as the overall appearance of skin. The use of an aqueous gel with 3% Cherimoya showed to increase wellbeing and quality of life and reduce persistent skin itching. New and larger studies with Cherimoya have


been performed on facial skin and are reported on in this article. In these new studies a comparison was made between three cohorts of volunteers with sensitive and/or atopic skin which used different facial skincare products for four weeks (twice daily application of the products). One cohort normally applied an oil-


in-water cream containing 3% Cherimoya, another normally applied the same formulation without Cherimoya (‘placebo’). A third cohort of volunteers applied the placebo with facial massage. One of the inclusion criteria for this last cohort of volunteers was that they enjoyed facial massage and found it pleasant and relaxing. The following massage technique was used


to standardize the facial massage and, before the start of the study, the volunteers were trained to performed the massage: Starting at the central line, gently and slowly


www.personalcaremagazine.com Minimal Slight Not


2.5 2.0 1.5 1.0 0.5 0


Cherimoya (3%) Figure 1: Evolution of skin sensitivity


stroke your forehead towards the temples. Repeat ten times. Connect your palms as in prayer. Place


fingers at each side of the nose, joining palms at the chin. Sweep gently and slowly from the central line towards your ears and over your earlobes. Repeat ten times. Cover your face with your fingers. Starting at


the top of the forehead, run your fingers down across your face as in a smooth caress. Repeat ten times. Breathe deeply and try to relax. Enjoy the


moment. Added to this training, a video was made


available to the volunteers in this cohort to help remind them how to apply the massage technique.


Skin sensitivity Sensitivity of skin was assessed at t = 0 and t = four weeks at the end of the study. The assessment took place by using capsaicin (Capsaicin Facial Neurosensitivity Test). Six test solutions were used, five dilutions of


capsaicin (C1, C2, C3, C4 and C5) and a vehicle control (V). The vehicle (V) was 10% ethanol (≥99.0% purity) with 90% water (sterile, distilled water) made as a volume/volume solution. The test site was the nasolabial fold, with the capsaicin applied to one side and the control applied to the other. The concentrations were as follows: ■ C1 = 3.16 x 10–5% (lowest concentration). ■ C2 = 1.0 x 10–4% ■ C3 = 3.16 x 10–4% ■ C4 = 1.0 x 10–3% ■ C5 = 3.16 x 10–3% (highest concentration). Capsaicin concentration was applied in


increasing concentrations with a three-minute wait between applications. The test subject was asked to describe the intensity of the feeling ( Table 1). The test was stopped when the subject


TABLE 1 Grade


1


2 3 4 5


Intensity


Doubtful, barely perceptible Slightly perceptible


Moderately perceptible Strongly perceptible Painful


Table 1: Capsaicin concentration was applied in increasing concentrations with a three-minute wait between applications. The test subject was asked to describe the intensity of the feeling


reported a sensation lasting more than 30 seconds on the capsaicin side. From this experiment, the so-called


capsaicin response was calculated (see figure 1), with some remarkable results. The treatment with Cherimoya led to a significant 30.3% reduction of skin sensitivity. Skin sensitivity was reduced one whole grade, from moderately sensitive to slightly sensitive. The treatments with placebo and the ones with the facial massage tendentially reduced skin sensitivity somewhat (11.5% and 13.8%, respectively), but these changes were not significant.


Skin appearance The condition of the skin of the face and neck was assessed by an expert assessor at t = 0 and t = four weeks. Assessments were made at each of the


following sites: ■ Cheeks ■ Area around the nostrils ■ Nasolabial folds The test sites were evaluated for signs of cutaneous irritation. Erythema was recorded using the following ranking scale:


April 2024 PERSONAL CARE


t = 0 weeks ■ ■ t = 4 weeks ■ ■


30.3% 11.5% 13.8%


35


Placebo


Placebo + Massage


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100  |  Page 101  |  Page 102  |  Page 103  |  Page 104  |  Page 105  |  Page 106  |  Page 107  |  Page 108  |  Page 109  |  Page 110  |  Page 111  |  Page 112  |  Page 113  |  Page 114  |  Page 115  |  Page 116  |  Page 117  |  Page 118  |  Page 119  |  Page 120  |  Page 121  |  Page 122  |  Page 123  |  Page 124  |  Page 125  |  Page 126  |  Page 127  |  Page 128  |  Page 129  |  Page 130  |  Page 131  |  Page 132  |  Page 133  |  Page 134  |  Page 135  |  Page 136  |  Page 137  |  Page 138  |  Page 139  |  Page 140  |  Page 141  |  Page 142  |  Page 143  |  Page 144  |  Page 145  |  Page 146  |  Page 147  |  Page 148  |  Page 149  |  Page 150  |  Page 151  |  Page 152  |  Page 153  |  Page 154